Document is current
Any future updates will be listed below
-
Authors
Pratibha,
Kaushik, Amit
Sarfraz, Aqib
Shah, Saumya
Sahu, Mridula
Khan, Feroz
Sundaresan, Velusamy
Khare, Puja
Shanker, Karuna
Mani, Daya N. https://orcid.org/0000-0002-3445-521X
Shukla, Ashutosh K. https://orcid.org/0000-0003-3419-9129
-
Funding
Funding for this research was provided by:
CSIR-CIMAP (In-house)
- License Information
-
More Information
Article History
Received: 26 October 2025
Accepted: 9 January 2026
First Online: 30 January 2026
Declarations
:
: The authors declare no competing interests.
: All animal experiments were performed as per guidelines provided by the OECD (1987), for use and care of laboratory animals, which mandates to have prior approval of the Institutional Animal Ethics Committee (IAEC) for establishing any disease model of experimental animals. Safety studies were conducted according to OECD guidelines 423 (acute toxicity) and 407 (sub-acute toxicity), in which every group had equal representation of females and males. Experimental protocols CIMAP/IAEC/2020–23/16 (antiallergic activity) and CIMAP/IAEC/2020–23/22 (safety studies) were duly approved by the IAEC of CSIR-CIMAP, Lucknow, formed under the Committee for Control and Supervision of Experiments on Animals (CCSEA), Govt. of India.
